troglitazone has been researched along with Anoxemia in 2 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Lane, SL | 1 |
Doyle, AS | 1 |
Bales, ES | 1 |
Houck, JA | 1 |
Lorca, RA | 1 |
Moore, LG | 1 |
Julian, CG | 1 |
Fürnsinn, C | 1 |
Neschen, S | 1 |
Noe, C | 1 |
Bisschop, M | 1 |
Roden, M | 1 |
Vogl, C | 1 |
Schneider, B | 1 |
Waldhäusl, W | 1 |
2 other studies available for troglitazone and Anoxemia
Article | Year |
---|---|
Peroxisome proliferator-activated receptor gamma blunts endothelin-1-mediated contraction of the uterine artery in a murine model of high-altitude pregnancy.
Topics: Animals; Disease Models, Animal; Endothelin-1; Female; Fetal Growth Retardation; Hypoxia; Immunohist | 2020 |
Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro.
Topics: Animals; Chromans; Drug Synergism; Glucose; Hypoglycemic Agents; Hypoxia; In Vitro Techniques; Insul | 1997 |